Patent · US Active

Method of classifying gene expression strength in lung cancer tissues

US8244478B2 · kind B2 · utility

0Cited by
2References
1Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 9, 2010
Grant dateAug 14, 2012
Priority date
Expiry dateNov 9, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides a method of confirming the gene expression, useful in the decision of a five year survival rate of a patient with lung cancer and the use of a DNA probe kit in the method. A method useful in the decision of a survival rate of a patient with non-small cell lung cancer comprising confirming the expression strength of at least one gene in lung cancer tissues isolated from the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.